We are looking forward to an exciting 2019 ARVO Annual Meeting "From Bench to Bedside and Back." Duke Faculty and trainees will participate in almost 90 sessions during the 5 day meeting being held in Vancouver, Canada.
See you soon for a time for innovative research, engaging discussion, and visiting with our colleagues and friends.
W. Daniel Stamer, PhD President-Elect
We are proud that W. Daniel Stamer, PhD will become the next president of ARVO. Stamer has been serving as an ARVO trustee representing the Physiology/Pharmacology (PH) Section for the past 3 years.
Stamer is the Joseph A.C. Wadsworth Professor of Ophthalmology and Professor of Biomedical Engineering at Duke University School of Medicine. His laboratory studies the disease of glaucoma using molecular, cellular and organ-based model systems, and seeks to identify and validate novel drug targets in the human conventional outflow pathway, such that novel treatment of ocular hypertension and glaucoma can be developed.
Expect great things for ARVO under his leadership.
Meeting Planning Committee Members
Noteworthy Presentations
Saturday, April 27
Catherine Bowes Rickman, PhDComplement Dysregulation/ Age-Related Macular Degeneration
Victor Perez, MD
Corneal Transplantation and Beyond
8 a.m. - 12 p.m.
(separate registration required)
Sunday, April 28
W. Daniel Stamer, PhD
The Importance of Targeting Trabecular Outflow for the Treatment of Glaucoma
China-ARVO Workshop
Scott Cousins, MD
Elamipretide, a Mitochondria-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with Noncentral Geographic Atrophy: Results of the Phase 1 ReCLAIM Study
Paper Session: Emerging AMD Therapeutics
3:00 p.m. - 4:45 p.m.
Monday, April 29
Vadim Arshavsky, PhD
How to Build a Photoreceptor Disc?
Mini Symposium: Frontiers in Membrane Dynamics and Cellular Communication: Impact on vision and disease mechanisms
8:15 a.m. - 10 a.m.
Eleonora Lad, MD, PhD
Vasantha Rao, PhDAnkyrin-B is required for lens fiber cell lateral membrane organization, hexagonal symmetry, tension and function
Paper Session: Lens Cell Biology
4:00 p.m. - 5:45 p.m.
W. Daniel Stamer, PhD4:00 p.m. - 5:45 p.m.
Tuesday, April 30
Anthony Kuo, MDCynthia Toth, MD
Joseph Izatt, PhD
Special Interest Group: OCT Guided and Robotically Enabled Ophthalmic Surgery panel
7:00 a.m. - 8:30 a.m.
Paper Session: Non-Melanoma Tumors: Genetics and Therapeutics
8:45 a.m. - 10:30 a.m.
Goldis Malek, PhD
Cooperative Roles of NURR1 with RXR and LXR in Retinal Pigment Epithelial (RPE) Cells Varies as a Function of Age and Aged-related Macular Degeneration (AMD)
Paper Session: RPE Biology in Health and Diseases
2:45 p.m. - 4:30 p.m.
Glenn Jaffe, MD
Treatment of Non-infectious Uveitis that Affects the Posterior Segment with a Single Intravitreal Fluocinolone Acetonide Insert (FAi) – 3-year results
Paper Session: Uveitis Clinical Epidemiology and Therapeutics
2:45 p.m.. - 4:30 p.m.
Wednesday, May 1
Victor Perez, MD
Immune Mediated Early Corneal Nerve Damage Ocular Graft-Versus-Host Disease
Paper Session: Corneal Neuropathy and Neovascularization
8:15 a.m. - 10:00 a.m.
Xi Chen, MD, PhD
Capturing Macular Neurovascular Development in Infants with Retinopathy of Prematurity
Paper Session: Retinopathy of Prematurity
10:45 a.m. - 11:00 a.m
Sina Farsiu, PhD12:15 p.m. - 1:45 p.m.
Thursday, May 2
Daniel Saban, PhD
Elucidatiing niche-associated function of retinal microglia at the single cell level
Symposium: The single cell revolution: Novel insights and applications for single cell RNA sequencing in eye research
8:00 a.m. - 12:00 p.m.